DBV Technologies (DBVT) Income towards Parent Company (2020 - 2026)

DBV Technologies (DBVT) reported Income towards Parent Company of -$47.6 million for Q1 2026, down 75.65% year-over-year from -$195.4 million in Q1 2025, and down 6.18% quarter-over-quarter from -$44.8 million in Q4 2025.

DBV Technologies (DBVT) Income towards Parent Company (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has 7 years of Income towards Parent Company data on file, last reported at -$47.6 million in Q1 2026.

  • Income towards Parent Company for Q1 2026 came in at -$47.6 million, down 75.65% year-over-year; the trailing twelve-month figure through Mar 2026 was -$167.5 million (down 47.32% YoY), and the FY2025 annual result was -$146.9 million, down 28.99% from the prior year.
  • Income towards Parent Company retreated to -$47.6 million in Q1 2026 per DBVT's latest filing, from -$44.8 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$11.2 million in Q4 2023 and troughed at -$47.6 million in Q1 2026.
  • A 5-year average of -$28.1 million and a median of -$27.1 million in 2025 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2022 and 2023: Income towards Parent Company slumped 187.02% in 2022, then surged 71.49% in 2023.
  • A 5-year view of Income towards Parent Company shows it stood at -$39.2 million in 2022, then surged by 71.49% to -$11.2 million in 2023, then plunged by 105.75% to -$23.0 million in 2024, then plunged by 94.78% to -$44.8 million in 2025, then declined by 6.18% to -$47.6 million in 2026.
  • Business Quant data shows DBVT's Income towards Parent Company at -$47.6 million in Q1 2026, -$44.8 million in Q4 2025, and -$33.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 DBV Technologies 6.63 Bn 6.41 Bn -3.90 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -47.60 Mn
Dec 31, 2025 -44.83 Mn
Sep 30, 2025 -33.16 Mn
Jun 30, 2025 -41.88 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 -23.02 Mn
Sep 30, 2024 -30.44 Mn
Jun 30, 2024 -33.12 Mn
Mar 31, 2024 -27.35 Mn
Dec 31, 2023 -11.19 Mn
Sep 30, 2023 -16.74 Mn
Jun 30, 2023 -24.24 Mn
Mar 31, 2023 -20.56 Mn
Dec 31, 2022 -39.24 Mn
Sep 30, 2022 -17.29 Mn
Jun 30, 2022 -23.04 Mn
Mar 31, 2022 -16.71 Mn
Dec 31, 2021 -13.67 Mn
Sep 30, 2021 -24.03 Mn
Jun 30, 2021 -30.65 Mn